BUSQUETS, JULI
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy (NCT05489458) | BUSQUETS, JULI | 2022-09-01 |
Track BUSQUETS, JULI automatically
Every clearance here is in the API, with alerts when new ones post.